<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Vivexia</title>
	<atom:link href="https://www.vivexia.fr/en/feed/" rel="self" type="application/rss+xml" />
	<link>https://vivexia.propulse.dev/en/</link>
	<description>Développement de modèles Pré-cliniques en pharmacologie des anti-infectueux</description>
	<lastBuildDate>Fri, 30 Oct 2026 15:17:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>
	<item>
		<title>&#x1f680; Our labs have a new home!&#x1f9ea;</title>
		<link>https://www.vivexia.fr/en/laboratoire-demenagement-laboratoire-nouveaux-locaux-etudes-clients-programmes-collaboratifs-innovation-rd-equipement-laboratoire/</link>
		
		<dc:creator><![CDATA[Delphine Croisier]]></dc:creator>
		<pubDate>Mon, 17 Aug 2026 12:34:06 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://www.vivexia.fr/?p=1311</guid>

					<description><![CDATA[<p>&#160; We&#8217;re proud to announce that our laboratories have moved into new premises, fully equipped to meet the requirements of your studies and to support our collaborative programs even more effectively. A new space, a motivated team, and the same commitment to quality — ready to take on your next challenges. Would you like to [&#8230;]</p>
<p>L’article <a href="https://www.vivexia.fr/en/laboratoire-demenagement-laboratoire-nouveaux-locaux-etudes-clients-programmes-collaboratifs-innovation-rd-equipement-laboratoire/">&#x1f680; Our labs have a new home!&#x1f9ea;</a> est apparu en premier sur <a href="https://www.vivexia.fr/en/">Vivexia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>&nbsp;</p>
<p class="font-claude-response-body break-words whitespace-normal" dir="ltr">We&#8217;re proud to announce that our laboratories have moved into new premises, fully equipped to meet the requirements of your studies and to support our collaborative programs even more effectively.</p>
<p class="font-claude-response-body break-words whitespace-normal" dir="ltr">A new space, a motivated team, and the same commitment to quality — ready to take on your next challenges.</p>
<p class="font-claude-response-body break-words whitespace-normal" dir="ltr">Would you like to visit our new facilities or discuss a collaboration? Get in touch.</p>
<p class="font-claude-response-body break-words whitespace-normal" dir="ltr">#Innovation #ResearchAndDevelopment #NewPremises</p>
<p>&nbsp;</p>
<p>L’article <a href="https://www.vivexia.fr/en/laboratoire-demenagement-laboratoire-nouveaux-locaux-etudes-clients-programmes-collaboratifs-innovation-rd-equipement-laboratoire/">&#x1f680; Our labs have a new home!&#x1f9ea;</a> est apparu en premier sur <a href="https://www.vivexia.fr/en/">Vivexia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Our team at the ECCMID annual conference in Copenhagen</title>
		<link>https://www.vivexia.fr/en/notre-equipe-au-congres-annuel-de-leccmid-a-copenhague/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 10 Feb 2023 14:13:05 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://vivexia.propulse.dev/notre-equipe-au-congres-annuel-de-leccmid-a-copenhague/</guid>

					<description><![CDATA[<p>Vivexia will present its data on multidrug resistant Acinetobacter baumannii pneumonia models (posters 2132 &#38; 2240) at the 33rd European Congress of Clinical Microbiology &#38; Infectious Diseases (ECCMID) which will be held from 15th to 18th April in Copenhagen! https://www.escmid.org/dates_events/eccmid</p>
<p>L’article <a href="https://www.vivexia.fr/en/notre-equipe-au-congres-annuel-de-leccmid-a-copenhague/">Our team at the ECCMID annual conference in Copenhagen</a> est apparu en premier sur <a href="https://www.vivexia.fr/en/">Vivexia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Vivexia will present its data on multidrug resistant Acinetobacter baumannii pneumonia models (posters 2132 &amp; 2240) at the 33rd European Congress of Clinical Microbiology &amp; Infectious Diseases (ECCMID) which will be held from 15th to 18th April in Copenhagen!</p>
<p><a href="https://www.escmid.org/dates_events/eccmid">https://www.escmid.org/dates_events/eccmid</a></p>
<p>L’article <a href="https://www.vivexia.fr/en/notre-equipe-au-congres-annuel-de-leccmid-a-copenhague/">Our team at the ECCMID annual conference in Copenhagen</a> est apparu en premier sur <a href="https://www.vivexia.fr/en/">Vivexia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Vivexia at the 7th AMR conference in Basel</title>
		<link>https://www.vivexia.fr/en/vivexia-membre-associe-de-la-beam-alliance-aura-le-plaisir-de-participer-a-la-7eme-conference-amr-a-bale-les-16-et-17-mars-2023/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 10 Feb 2023 14:07:20 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://vivexia.propulse.dev/vivexia-membre-associe-de-la-beam-alliance-aura-le-plaisir-de-participer-a-la-7eme-conference-amr-a-bale-les-16-et-17-mars-2023/</guid>

					<description><![CDATA[<p>Vivexia, associate member of the BEAM ALLIANCE, will be pleased to attend the upcoming AMR conference (novel antimicrobials and AMR diagnostics) on March 16-17th 2023 in Basel. https://amr-conference.com/</p>
<p>L’article <a href="https://www.vivexia.fr/en/vivexia-membre-associe-de-la-beam-alliance-aura-le-plaisir-de-participer-a-la-7eme-conference-amr-a-bale-les-16-et-17-mars-2023/">Vivexia at the 7th AMR conference in Basel</a> est apparu en premier sur <a href="https://www.vivexia.fr/en/">Vivexia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Vivexia, associate member of the BEAM ALLIANCE, will be pleased to attend the upcoming AMR conference (novel antimicrobials and AMR diagnostics) on March 16-17th 2023 in Basel.</p>
<p><a href="https://amr-conference.com/" target="_blank" rel="noopener">https://amr-conference.com/</a></p>
<p>L’article <a href="https://www.vivexia.fr/en/vivexia-membre-associe-de-la-beam-alliance-aura-le-plaisir-de-participer-a-la-7eme-conference-amr-a-bale-les-16-et-17-mars-2023/">Vivexia at the 7th AMR conference in Basel</a> est apparu en premier sur <a href="https://www.vivexia.fr/en/">Vivexia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
